Inactivation of the cardiomyocyte glucagon-like peptide-1 receptor (GLP-1R) unmasks cardiomyocyte-independent GLP-1R-mediated cardioprotection.
about
Cardiomyocyte-specific loss of diacylglycerol acyltransferase 1 (DGAT1) reproduces the abnormalities in lipids found in severe heart failure.Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrixInhibition of DPP-4 reduces acute mortality after myocardial infarction with restoration of autophagic response in type 2 diabetic rats.Exenatide Activates the APPL1-AMPK-PPARα Axis to Prevent Diabetic Cardiomyocyte Apoptosis.Protection against cardiac hypertrophy by geniposide involves the GLP-1 receptor / AMPKα signalling pathwayMetabolically-inactive glucagon-like peptide-1(9-36)amide confers selective protective actions against post-myocardial infarction remodelling.Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical ConsiderationsIslet α cells and glucagon--critical regulators of energy homeostasis.Mechanisms for the cardiovascular effects of glucagon-like peptide-1.A review of glucagon-like peptide-1 receptor agonists and their effects on lowering postprandial plasma glucose and cardiovascular outcomes in the treatment of type 2 diabetes mellitus.GLP-1 receptor independent pathways: emerging beneficial effects of GLP-1 breakdown products.Glucagon-like peptide-1 (GLP-1) mediates cardioprotection by remote ischaemic conditioning.Exendin-4 attenuates adverse cardiac remodelling in streptozocin-induced diabetes via specific actions on infiltrating macrophages.Cardiomyocyte glucagon receptor signaling modulates outcomes in mice with experimental myocardial infarction.The autonomic nervous system and cardiac GLP-1 receptors control heart rate in mice.Bile acids at the cross-roads of gut microbiome-host cardiometabolic interactions.Female offspring born to obese and insulin-resistant dams are not at increased risk for obesity and metabolic dysfunction during early development.Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk factors: A narrative review of head-to-head comparisons.FoxO1 regulates myocardial glucose oxidation rates via transcriptional control of pyruvate dehydrogenase kinase 4 expression.Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived?Cardiac-Specific Deletion of Pyruvate Dehydrogenase Impairs Glucose Oxidation Rates and Induces Diastolic Dysfunction.Molecular and cellular mechanisms of glucagon-like peptide-1 receptor agonist-mediated attenuation of cardiac fibrosis.Accumulation of ceramide in slow-twitch muscle contributes to the development of insulin resistance in the obese JCR:LA-cp rat.Deciphering ventricular GLP-1 action: time for a change of heart.Long-Acting GLP-1 Receptor Agonist Exenatide Influence on the Autonomic Cardiac Sympatho-Vagal Balance.
P2860
Q34396881-CD4FE15D-1254-4654-A655-EA87D5C1857FQ35132702-005FABDA-5750-4018-BA07-E581F77FCCC5Q35936441-40F815E0-02C4-4087-A4D5-4CF172F916DCQ36366910-9C26DEF1-B9B7-4136-8F02-33D8050072BEQ36797390-7D844DC0-3C30-4F98-B7BC-E3BD3547CB3EQ36800422-446DAAE1-A2B9-4CDC-81DF-89211254DEB8Q37011769-1D6BDED6-783E-423B-B1EB-E5AEEE1FFE99Q38409880-E3876B87-0CE2-4AE5-8B24-3745359A9036Q38589032-041D106A-6112-43B1-A2EE-8A10E7CC9AB3Q38802810-4EBA161F-8B79-4B99-95AD-F4BB8A0AE686Q39063954-28DD429C-1024-4FC0-AAE0-41C3C04218B6Q39323549-AC4A7985-DC85-44C7-BA43-FFF0EF3B611FQ41878782-471B6985-4077-4A71-9C6F-DBD89EA5166DQ42170069-3FF7D525-7725-46EB-9402-E60696617922Q46906226-841298E0-7868-4E49-BB85-C2CF9AE27DB7Q47134180-0356F00E-D46C-4F41-9BCF-9E69927D41ABQ47646506-002B3583-B7BE-4D9E-B2FC-43E2DFC4D736Q47811538-DF4C3036-86FF-409D-A7AC-1E9AD8CC32CDQ47834016-D140983F-2458-49E1-BB31-817CC2D832CBQ47849041-3AF6FC1E-D8F2-4D53-B52E-36FC9CE75E32Q51737417-096768EA-2F72-4FC3-B8F3-1126DB1ACD70Q53337186-2387AFDB-51CF-4B6D-ABCE-C7EAFFF518A9Q53573537-8B52C8DA-EB01-426D-ABDD-DC0923028B84Q54319337-D7D91A47-7506-4EAE-8B05-2048E2C7D4A9Q55090958-04F083BB-37BA-4A6C-BF58-8FD7451BE660
P2860
Inactivation of the cardiomyocyte glucagon-like peptide-1 receptor (GLP-1R) unmasks cardiomyocyte-independent GLP-1R-mediated cardioprotection.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Inactivation of the cardiomyoc ...... -1R-mediated cardioprotection.
@en
Inactivation of the cardiomyocyte glucagon-like peptide-1 receptor
@nl
type
label
Inactivation of the cardiomyoc ...... -1R-mediated cardioprotection.
@en
Inactivation of the cardiomyocyte glucagon-like peptide-1 receptor
@nl
prefLabel
Inactivation of the cardiomyoc ...... -1R-mediated cardioprotection.
@en
Inactivation of the cardiomyocyte glucagon-like peptide-1 receptor
@nl
P2093
P2860
P1433
P1476
Inactivation of the cardiomyoc ...... -1R-mediated cardioprotection.
@en
P2093
Benjamin M Baranek
Doris A Stoffers
Erin E Mulvihill
John R Ussher
Jonathan E Campbell
Laurie L Baggio
M Golam Kabir
Minsuk Kim
Xiemin Cao
P2860
P304
P356
10.1016/J.MOLMET.2014.04.009
P577
2014-05-09T00:00:00Z